See also this year's filing and all EDGAR filings for this company.
PDF Report 0000874015_2020_IONIS_PHARMACEUTICALS_INC.pdf
Logs
| warning | Large missing amount for aggregate "Liabilities" added to remainder. | industry.us_generic | {'missing_ratio': 0.8467814163270807, 'aggregate_val': 1548565000, 'exp_sum': 838521000, 'exp_to_value': {'LiabilitiesCurrent': 273005000, 'LiabilitiesNoncurrent': 490060000, 'remainder_Liabilities': 75456000}} |
| info | Added remainder_ComprehensiveNetIncome directly from 10K | industry.us_generic | {} |
Graph
Absolute values for 0000874015, IONIS PHARMACEUTICALS INC
| xvar | xval | |
|---|---|---|
| 0 | AssetsCurrent | 2,720,597,000 |
| 1 | IntangibleAssetsNetIncludingGoodwill | 25,674,000 |
| 2 | PropertyPlantAndEquipmentNet | 153,651,000 |
| 3 | remainder_Assets | 333,190,000 |
| 4 | LiabilitiesCurrent | 273,005,000 |
| 5 | LiabilitiesNoncurrent | 490,060,000 |
| 6 | remainder_Liabilities | 785,500,000 |
| 7 | CostOfGoodsAndServicesSold | 4,384,000 |
| 8 | SellingGeneralAndAdministrativeExpense | 286,644,000 |
| 9 | ResearchAndDevelopmentExpense | 0 |
| 10 | remainder_Expenses | 557,963,000 |
| 11 | remainder_Revenues | 1,122,599,000 |
| 12 | remainder_NetIncome | 29,654,000 |
| 13 | remainder_ComprehensiveNetIncome | -2,392,000 |
| yvar | yval | |
|---|---|---|
| 0 | Assets | 3,233,112,000 |
| 1 | Liabilities | 1,548,565,000 |
| 2 | Expenses | 848,991,000 |
| 3 | Revenues | 1,122,599,000 |
| 4 | StockholdersEquity | 1,684,547,000 |
| 5 | NetIncome | 303,262,000 |
| 6 | ComprehensiveNetIncome | 302,066,000 |
| 7 | BaseVar | 3,392,656,500 |
| 8 | EconomicCapitalRatio | 1.34 |
Edgar->Model Mapping
Feature Distribution
Change over Time
